E 5296
Latest Information Update: 26 Feb 2010
At a glance
- Originator Esteve
- Class
- Mechanism of Action Opioid receptor agonists; Serotonin uptake stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 25 Jul 2001 Phase-I clinical trials for Pain (Unknown route)
- 04 Apr 2000 Preclinical development for Pain (Unknown route)